Compassionate Care, Pioneering Research is the theme of The Friedman Brain Institute’s semi-annual newsletter.
The newsletter provides updates on research and clinical advances in brain and spinal cord disorders across the Mount Sinai Health System campus. Our goal is to increase awareness of ongoing research and clinical work at Mount Sinai and to foster innovative and multidisciplinary approaches to these illnesses. Read the latest issue.
Our newest Fall issue of The Friedman Brain Institute (FBI) Report focuses the laboratory of Christoph Buettner, MD, PhD, is developing neuroscience inspired techniques in which specialized molecular probes that emit light in response to neurotransmission are inserted into hepatic and pancreatic cells.
In the latest issue of the Friedman Brain Institute newsletter highlights the Seaver Autism Center, celebrating 25 years in progress in the fields of autism research, diagnosis, and treatment. Also, in this issue; the 2019 Friedman Brain Institute Research Scholars Program recipients.
The latest Fall issue of The Friedman Brain Institute (FBI) Report focuses on the Advanced Neuroimaging Research Program, the Center for Affective Neuroscience and other research centers and programs aiming for bold new discoveries.
This issue of The Friedman Brain Institute newsletter highlights the creation of our new Center for Advanced Circuit Therapeutics at the Icahn School of Medicine at Mount Sinai, which is led by Helen S. Mayberg, MD, recruited to Mount Sinai earlier this year.
Many types of seizures can present in very different ways, including focal seizures that affect more limited parts of the brain and body, in some cases presenting with predominantly psychiatric symptoms. In this latest issue of the Friedman Brain Institute newsletter, Epilepsy describes a collection of neurological disorders that are characterized by episodes of excessive brain activity manifesting as seizures.
This issue of The Friedman Brain Institutie (FBI) Report focuses on the importance of a sustained investiment in basic, fundamental neuroscience in advancing our understanding, diagnosis, and treatment of brain diseases.
The last strategice plan — launched roughly 10 years ago — has resulted in unprecedented expansion of our neuroscience community throught the recruitment of more neuroscientists, clinical researchers and clincians. The dividends are impressive: The Department of Neuroscience is ranked No. 3 in the nation in National Institutes of Health (NIH) funding; Psychiatry is ranked No. 7; and Neurology, No. 11. U.S. News & World Report has ranked our clinical neurology and neurosurgery programs No. 12 in the nation.
Highlighted in this issue of the Friedman Brain Institute newsletter are the recent efforts in PyschENCODE, a national effort to define the epigenomic basis of psychiatric disorders, innovative research by Don Des Jarlais, PhD, on HIV and drug abuse, our commitment to diversity in the neurosciences and the announcement of the inaugural recipients of our FBI Research Scholars Partnership.
This fall the Friedman Brain Institute welcomes Barbara G. Vickrey, MD MPH as Chair of the Department of Neurology and builds upon considerable research contributions to the neurobiology of drug addiction by creating a Center for Addictive Disorders, under the direction of Yasmin Hurd, PhD.
This issue focuses on the continued efforts lead by Mount Sinai in studying Alzheimer's Disease and other dementias with the recently established Ronald M. Loeb Center for Alzheimer's Disease.
This issue of The Friedman Brain Institute newsletter focuses on a complementary research approach–the ability to induce neurons and glial cells from a patient's skin biopsy or blood.
This issue highlights two developments that greatly enhanced the neurosciences at Mount Sinai: the creation of an advanced brain imaging program and the establishment of the new Mount Sinai Health System.
This issue showcases five recent junior faculty who have been recruited to The Friedman Brain Institute at Mount Sinai in recent years, who exemplify the dramatic expansion in scope and depth, and exciting translational potential, of our neuroscience research programs.
This issue highlights two recent senior faculty who recently joined The Friedman Brain Institute as part of the major expansion in the neuroscience community at Mount Sinai made possible by the opening of the new Hess Center for Science and Medicine in December 2012.
This issue reviews Mount Sinai's many exciting programs currently underway in the research and clinical care of movement disorders, important progress which is continuing our distinguished history in this area of neuroscience.
This issue highlights the work of two of our leading researchers in cognitive neuroscience and brain aging, and outlines exciting new initiatives that pave the way toward clinical advances for a range of neurological and psychiatric disorders.
This issue focuses on epigenetic research currently underway within The Friedman Brain Institute at Mount Sinai. Epigenetics describes an excited new field of study that examines the complex molecular mechanisms controlling gene expression in the nervous system that seems to play an important role in several brain disorders.
This issue focuses on two areas of exciting research at Mount Sinai, one focused on the analysis of individual synapses in brain and their deterioration in models of Alzheimer’s disease. The other area is focused on the genetics of psychiatric disorders, including schizophrenia, bipolar disorder, and autism.
This issue introduces the FBI and its organization structure, presents new research findings related to Alzheimer’s disease and to cognition, and highlights a history of research breakthroughs in the neurosciences at Mount Sinai.